Bluejay Diagnostics
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Bluejay Diagnostics generated cash of -$8,313,870, which is less than the previous year. Cash used in financing activities reached the amount of $1,111,562 last year. Net change in cash is therefore -$7,906,474.

Cash Flow

Bluejay Diagnostics, Inc. (NASDAQ:BJDX): Cash Flow
2019 -1.69M -6.02K 1.51M
2020 -508.71K 0 1.32M
2021 -4.36M -23.94K 22.52M
2022 -7.74M -1.19M 8.07K
2023 -8.31M -704.16K 1.11M

BJDX Cash Flow Statement (2019 โ€“ 2023)

2023 2022 2021 2020 2019
Cash at beginning of period
10.11M19.04M912.36K96.01K280.34K
Operating activities
Net income
-9.95M-9.29M-3.48M-1.15M-819.84K
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
780.95K306.36K145.71K157.03K142.97K
Stock-based compensation expense
189.24K433.00K68.45K7.37K14.81K
Deferred income tax benefit 189.24K433.00K68.45K7.37K14.81K
Changes in operating assets and liabilities:
Accounts receivable, net
000645-645
Inventories
0084.76K38.74K-103.87K
Accounts payable
-235.76K298.88K-79.15K345.80K-25.21K
Cash generated by operating activities
-8.31M-7.74M-4.36M-508.71K-1.69M
Investing activities
Purchases Of Investments
00000
Investments In Property Plant And Equipment
-704.16K-1.19M-23.94K0-6.02K
Acquisitions Net
00000
Cash generated by investing activities
-704.16K-1.19M-23.94K0-6.02K
Financing activities
Common Stock Issued
159.84K28.87K31.70K1.05M1.67M
Payments for dividends
00000
Repurchases of common stock
00000
Repayments of term debt
-4.80K-801-22.49M-270K-265K
Cash used in financing activities
1.11M8.07K22.52M1.32M1.51M
Net Change In Cash
-7.90M-8.93M18.13M816.35K-184.33K
Cash at end of period
2.20M10.11M19.04M912.36K96.01K
Data sourceData sourceData source